Pharma & Healthcare
Global Biliary Tumor Market Insights, Forecast to 2030
- Mar 07, 25
- ID: 2870
- Pages: 94
- Figures: 114
- Views: 5
Biliary Tumor is a form of cancer that develops in the bile duct system, which connects the liver, gallbladder, and small intestine, moving bile – a fluid that helps digest fats – to the small intestine.
Market Analysis and Insights: Global Biliary Tumor Market
The global Biliary Tumor market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Biliary Tumor is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Biliary Tumor is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Biliary Tumor is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Biliary Tumor include NuCana, NeoGenomics, Novartis, GlaxoSmithKline and Southwest Oncology Group, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Biliary Tumor is widely used in various fields, such as Hospitals, Clinics and Other,, etc. Hospitals provides greatest supports to the Biliary Tumor industry development. In 2023, global % revenue of Biliary Tumor went into Hospitals filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Biliary Tumor market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Biliary Tumor, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Biliary Tumor, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biliary Tumor revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Biliary Tumor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Biliary Tumor revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
NuCana
NeoGenomics
Novartis
GlaxoSmithKline
Southwest Oncology Group
Segment by Type
Mecine
Surgery
Other
Segment by Application
Hospitals
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Biliary Tumor in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biliary Tumor companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biliary Tumor revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Market Analysis and Insights: Global Biliary Tumor Market
The global Biliary Tumor market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Biliary Tumor is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Biliary Tumor is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Biliary Tumor is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Biliary Tumor include NuCana, NeoGenomics, Novartis, GlaxoSmithKline and Southwest Oncology Group, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Biliary Tumor is widely used in various fields, such as Hospitals, Clinics and Other,, etc. Hospitals provides greatest supports to the Biliary Tumor industry development. In 2023, global % revenue of Biliary Tumor went into Hospitals filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Biliary Tumor market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Biliary Tumor, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Biliary Tumor, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biliary Tumor revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Biliary Tumor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Biliary Tumor revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
NuCana
NeoGenomics
Novartis
GlaxoSmithKline
Southwest Oncology Group
Segment by Type
Mecine
Surgery
Other
Segment by Application
Hospitals
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Biliary Tumor in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biliary Tumor companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biliary Tumor revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biliary Tumor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Mecine
1.2.3 Surgery
1.2.4 Other
1.3 Market by Application
1.3.1 Global Biliary Tumor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biliary Tumor Market Perspective (2019-2030)
2.2 Global Biliary Tumor Growth Trends by Region
2.2.1 Biliary Tumor Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biliary Tumor Historic Market Size by Region (2019-2024)
2.2.3 Biliary Tumor Forecasted Market Size by Region (2025-2030)
2.3 Biliary Tumor Market Dynamics
2.3.1 Biliary Tumor Industry Trends
2.3.2 Biliary Tumor Market Drivers
2.3.3 Biliary Tumor Market Challenges
2.3.4 Biliary Tumor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Biliary Tumor by Players
3.1.1 Global Biliary Tumor Revenue by Players (2019-2024)
3.1.2 Global Biliary Tumor Revenue Market Share by Players (2019-2024)
3.2 Global Biliary Tumor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Biliary Tumor, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Biliary Tumor Market Concentration Ratio
3.4.1 Global Biliary Tumor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biliary Tumor Revenue in 2023
3.5 Global Key Players of Biliary Tumor Head office and Area Served
3.6 Global Key Players of Biliary Tumor, Product and Application
3.7 Global Key Players of Biliary Tumor, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biliary Tumor Breakdown Data by Type
4.1 Global Biliary Tumor Historic Market Size by Type (2019-2024)
4.2 Global Biliary Tumor Forecasted Market Size by Type (2025-2030)
5 Biliary Tumor Breakdown Data by Application
5.1 Global Biliary Tumor Historic Market Size by Application (2019-2024)
5.2 Global Biliary Tumor Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biliary Tumor Market Size (2019-2030)
6.2 North America Biliary Tumor Market Size by Type
6.2.1 North America Biliary Tumor Market Size by Type (2019-2024)
6.2.2 North America Biliary Tumor Market Size by Type (2025-2030)
6.2.3 North America Biliary Tumor Market Share by Type (2019-2030)
6.3 North America Biliary Tumor Market Size by Application
6.3.1 North America Biliary Tumor Market Size by Application (2019-2024)
6.3.2 North America Biliary Tumor Market Size by Application (2025-2030)
6.3.3 North America Biliary Tumor Market Share by Application (2019-2030)
6.4 North America Biliary Tumor Market Size by Country
6.4.1 North America Biliary Tumor Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Biliary Tumor Market Size by Country (2019-2024)
6.4.3 North America Biliary Tumor Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Biliary Tumor Market Size (2019-2030)
7.2 Europe Biliary Tumor Market Size by Type
7.2.1 Europe Biliary Tumor Market Size by Type (2019-2024)
7.2.2 Europe Biliary Tumor Market Size by Type (2025-2030)
7.2.3 Europe Biliary Tumor Market Share by Type (2019-2030)
7.3 Europe Biliary Tumor Market Size by Application
7.3.1 Europe Biliary Tumor Market Size by Application (2019-2024)
7.3.2 Europe Biliary Tumor Market Size by Application (2025-2030)
7.3.3 Europe Biliary Tumor Market Share by Application (2019-2030)
7.4 Europe Biliary Tumor Market Size by Country
7.4.1 Europe Biliary Tumor Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Biliary Tumor Market Size by Country (2019-2024)
7.4.3 Europe Biliary Tumor Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Biliary Tumor Market Size (2019-2030)
8.2 China Biliary Tumor Market Size by Type
8.2.1 China Biliary Tumor Market Size by Type (2019-2024)
8.2.2 China Biliary Tumor Market Size by Type (2025-2030)
8.2.3 China Biliary Tumor Market Share by Type (2019-2030)
8.3 China Biliary Tumor Market Size by Application
8.3.1 China Biliary Tumor Market Size by Application (2019-2024)
8.3.2 China Biliary Tumor Market Size by Application (2025-2030)
8.3.3 China Biliary Tumor Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Biliary Tumor Market Size (2019-2030)
9.2 Asia Biliary Tumor Market Size by Type
9.2.1 Asia Biliary Tumor Market Size by Type (2019-2024)
9.2.2 Asia Biliary Tumor Market Size by Type (2025-2030)
9.2.3 Asia Biliary Tumor Market Share by Type (2019-2030)
9.3 Asia Biliary Tumor Market Size by Application
9.3.1 Asia Biliary Tumor Market Size by Application (2019-2024)
9.3.2 Asia Biliary Tumor Market Size by Application (2025-2030)
9.3.3 Asia Biliary Tumor Market Share by Application (2019-2030)
9.4 Asia Biliary Tumor Market Size by Region
9.4.1 Asia Biliary Tumor Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Biliary Tumor Market Size by Region (2019-2024)
9.4.3 Asia Biliary Tumor Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Biliary Tumor Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Biliary Tumor Market Size by Type
10.2.1 Middle East, Africa, and Latin America Biliary Tumor Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Biliary Tumor Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Biliary Tumor Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Biliary Tumor Market Size by Application
10.3.1 Middle East, Africa, and Latin America Biliary Tumor Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Biliary Tumor Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Biliary Tumor Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Biliary Tumor Market Size by Country
10.4.1 Middle East, Africa, and Latin America Biliary Tumor Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Biliary Tumor Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Biliary Tumor Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 NuCana
11.1.1 NuCana Company Details
11.1.2 NuCana Business Overview
11.1.3 NuCana Biliary Tumor Introduction
11.1.4 NuCana Revenue in Biliary Tumor Business (2019-2024)
11.1.5 NuCana Recent Developments
11.2 NeoGenomics
11.2.1 NeoGenomics Company Details
11.2.2 NeoGenomics Business Overview
11.2.3 NeoGenomics Biliary Tumor Introduction
11.2.4 NeoGenomics Revenue in Biliary Tumor Business (2019-2024)
11.2.5 NeoGenomics Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Biliary Tumor Introduction
11.3.4 Novartis Revenue in Biliary Tumor Business (2019-2024)
11.3.5 Novartis Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Biliary Tumor Introduction
11.4.4 GlaxoSmithKline Revenue in Biliary Tumor Business (2019-2024)
11.4.5 GlaxoSmithKline Recent Developments
11.5 Southwest Oncology Group
11.5.1 Southwest Oncology Group Company Details
11.5.2 Southwest Oncology Group Business Overview
11.5.3 Southwest Oncology Group Biliary Tumor Introduction
11.5.4 Southwest Oncology Group Revenue in Biliary Tumor Business (2019-2024)
11.5.5 Southwest Oncology Group Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biliary Tumor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Mecine
1.2.3 Surgery
1.2.4 Other
1.3 Market by Application
1.3.1 Global Biliary Tumor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biliary Tumor Market Perspective (2019-2030)
2.2 Global Biliary Tumor Growth Trends by Region
2.2.1 Biliary Tumor Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biliary Tumor Historic Market Size by Region (2019-2024)
2.2.3 Biliary Tumor Forecasted Market Size by Region (2025-2030)
2.3 Biliary Tumor Market Dynamics
2.3.1 Biliary Tumor Industry Trends
2.3.2 Biliary Tumor Market Drivers
2.3.3 Biliary Tumor Market Challenges
2.3.4 Biliary Tumor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Biliary Tumor by Players
3.1.1 Global Biliary Tumor Revenue by Players (2019-2024)
3.1.2 Global Biliary Tumor Revenue Market Share by Players (2019-2024)
3.2 Global Biliary Tumor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Biliary Tumor, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Biliary Tumor Market Concentration Ratio
3.4.1 Global Biliary Tumor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biliary Tumor Revenue in 2023
3.5 Global Key Players of Biliary Tumor Head office and Area Served
3.6 Global Key Players of Biliary Tumor, Product and Application
3.7 Global Key Players of Biliary Tumor, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biliary Tumor Breakdown Data by Type
4.1 Global Biliary Tumor Historic Market Size by Type (2019-2024)
4.2 Global Biliary Tumor Forecasted Market Size by Type (2025-2030)
5 Biliary Tumor Breakdown Data by Application
5.1 Global Biliary Tumor Historic Market Size by Application (2019-2024)
5.2 Global Biliary Tumor Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biliary Tumor Market Size (2019-2030)
6.2 North America Biliary Tumor Market Size by Type
6.2.1 North America Biliary Tumor Market Size by Type (2019-2024)
6.2.2 North America Biliary Tumor Market Size by Type (2025-2030)
6.2.3 North America Biliary Tumor Market Share by Type (2019-2030)
6.3 North America Biliary Tumor Market Size by Application
6.3.1 North America Biliary Tumor Market Size by Application (2019-2024)
6.3.2 North America Biliary Tumor Market Size by Application (2025-2030)
6.3.3 North America Biliary Tumor Market Share by Application (2019-2030)
6.4 North America Biliary Tumor Market Size by Country
6.4.1 North America Biliary Tumor Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Biliary Tumor Market Size by Country (2019-2024)
6.4.3 North America Biliary Tumor Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Biliary Tumor Market Size (2019-2030)
7.2 Europe Biliary Tumor Market Size by Type
7.2.1 Europe Biliary Tumor Market Size by Type (2019-2024)
7.2.2 Europe Biliary Tumor Market Size by Type (2025-2030)
7.2.3 Europe Biliary Tumor Market Share by Type (2019-2030)
7.3 Europe Biliary Tumor Market Size by Application
7.3.1 Europe Biliary Tumor Market Size by Application (2019-2024)
7.3.2 Europe Biliary Tumor Market Size by Application (2025-2030)
7.3.3 Europe Biliary Tumor Market Share by Application (2019-2030)
7.4 Europe Biliary Tumor Market Size by Country
7.4.1 Europe Biliary Tumor Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Biliary Tumor Market Size by Country (2019-2024)
7.4.3 Europe Biliary Tumor Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Biliary Tumor Market Size (2019-2030)
8.2 China Biliary Tumor Market Size by Type
8.2.1 China Biliary Tumor Market Size by Type (2019-2024)
8.2.2 China Biliary Tumor Market Size by Type (2025-2030)
8.2.3 China Biliary Tumor Market Share by Type (2019-2030)
8.3 China Biliary Tumor Market Size by Application
8.3.1 China Biliary Tumor Market Size by Application (2019-2024)
8.3.2 China Biliary Tumor Market Size by Application (2025-2030)
8.3.3 China Biliary Tumor Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Biliary Tumor Market Size (2019-2030)
9.2 Asia Biliary Tumor Market Size by Type
9.2.1 Asia Biliary Tumor Market Size by Type (2019-2024)
9.2.2 Asia Biliary Tumor Market Size by Type (2025-2030)
9.2.3 Asia Biliary Tumor Market Share by Type (2019-2030)
9.3 Asia Biliary Tumor Market Size by Application
9.3.1 Asia Biliary Tumor Market Size by Application (2019-2024)
9.3.2 Asia Biliary Tumor Market Size by Application (2025-2030)
9.3.3 Asia Biliary Tumor Market Share by Application (2019-2030)
9.4 Asia Biliary Tumor Market Size by Region
9.4.1 Asia Biliary Tumor Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Biliary Tumor Market Size by Region (2019-2024)
9.4.3 Asia Biliary Tumor Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Biliary Tumor Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Biliary Tumor Market Size by Type
10.2.1 Middle East, Africa, and Latin America Biliary Tumor Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Biliary Tumor Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Biliary Tumor Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Biliary Tumor Market Size by Application
10.3.1 Middle East, Africa, and Latin America Biliary Tumor Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Biliary Tumor Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Biliary Tumor Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Biliary Tumor Market Size by Country
10.4.1 Middle East, Africa, and Latin America Biliary Tumor Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Biliary Tumor Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Biliary Tumor Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 NuCana
11.1.1 NuCana Company Details
11.1.2 NuCana Business Overview
11.1.3 NuCana Biliary Tumor Introduction
11.1.4 NuCana Revenue in Biliary Tumor Business (2019-2024)
11.1.5 NuCana Recent Developments
11.2 NeoGenomics
11.2.1 NeoGenomics Company Details
11.2.2 NeoGenomics Business Overview
11.2.3 NeoGenomics Biliary Tumor Introduction
11.2.4 NeoGenomics Revenue in Biliary Tumor Business (2019-2024)
11.2.5 NeoGenomics Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Biliary Tumor Introduction
11.3.4 Novartis Revenue in Biliary Tumor Business (2019-2024)
11.3.5 Novartis Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Biliary Tumor Introduction
11.4.4 GlaxoSmithKline Revenue in Biliary Tumor Business (2019-2024)
11.4.5 GlaxoSmithKline Recent Developments
11.5 Southwest Oncology Group
11.5.1 Southwest Oncology Group Company Details
11.5.2 Southwest Oncology Group Business Overview
11.5.3 Southwest Oncology Group Biliary Tumor Introduction
11.5.4 Southwest Oncology Group Revenue in Biliary Tumor Business (2019-2024)
11.5.5 Southwest Oncology Group Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Biliary Tumor Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Mecine
Table 3. Key Players of Surgery
Table 4. Key Players of Other
Table 5. Global Biliary Tumor Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global Biliary Tumor Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Biliary Tumor Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Biliary Tumor Market Share by Region (2019-2024)
Table 9. Global Biliary Tumor Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Biliary Tumor Market Share by Region (2025-2030)
Table 11. Biliary Tumor Market Trends
Table 12. Biliary Tumor Market Drivers
Table 13. Biliary Tumor Market Challenges
Table 14. Biliary Tumor Market Restraints
Table 15. Global Biliary Tumor Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Biliary Tumor Revenue Share by Players (2019-2024)
Table 17. Global Top Biliary Tumor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biliary Tumor as of 2023)
Table 18. Global Biliary Tumor Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by Biliary Tumor Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Biliary Tumor, Headquarters and Area Served
Table 21. Global Key Players of Biliary Tumor, Product and Application
Table 22. Global Key Players of Biliary Tumor, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biliary Tumor Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Biliary Tumor Revenue Market Share by Type (2019-2024)
Table 26. Global Biliary Tumor Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Biliary Tumor Revenue Market Share by Type (2025-2030)
Table 28. Global Biliary Tumor Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Biliary Tumor Revenue Share by Application (2019-2024)
Table 30. Global Biliary Tumor Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Biliary Tumor Revenue Share by Application (2025-2030)
Table 32. North America Biliary Tumor Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America Biliary Tumor Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America Biliary Tumor Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America Biliary Tumor Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America Biliary Tumor Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Biliary Tumor Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Biliary Tumor Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Biliary Tumor Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe Biliary Tumor Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe Biliary Tumor Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe Biliary Tumor Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe Biliary Tumor Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe Biliary Tumor Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe Biliary Tumor Market Size by Country (2025-2030) & (US$ Million)
Table 46. China Biliary Tumor Market Size by Type (2019-2024) & (US$ Million)
Table 47. China Biliary Tumor Market Size by Type (2025-2030) & (US$ Million)
Table 48. China Biliary Tumor Market Size by Application (2019-2024) & (US$ Million)
Table 49. China Biliary Tumor Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia Biliary Tumor Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia Biliary Tumor Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia Biliary Tumor Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia Biliary Tumor Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Biliary Tumor Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia Biliary Tumor Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia Biliary Tumor Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Biliary Tumor Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Biliary Tumor Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Biliary Tumor Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Biliary Tumor Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Biliary Tumor Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America Biliary Tumor Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Biliary Tumor Market Size by Country (2025-2030) & (US$ Million)
Table 64. NuCana Company Details
Table 65. NuCana Business Overview
Table 66. NuCana Biliary Tumor Product
Table 67. NuCana Revenue in Biliary Tumor Business (2019-2024) & (US$ Million)
Table 68. NuCana Recent Developments
Table 69. NeoGenomics Company Details
Table 70. NeoGenomics Business Overview
Table 71. NeoGenomics Biliary Tumor Product
Table 72. NeoGenomics Revenue in Biliary Tumor Business (2019-2024) & (US$ Million)
Table 73. NeoGenomics Recent Developments
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Biliary Tumor Product
Table 77. Novartis Revenue in Biliary Tumor Business (2019-2024) & (US$ Million)
Table 78. Novartis Recent Developments
Table 79. GlaxoSmithKline Company Details
Table 80. GlaxoSmithKline Business Overview
Table 81. GlaxoSmithKline Biliary Tumor Product
Table 82. GlaxoSmithKline Revenue in Biliary Tumor Business (2019-2024) & (US$ Million)
Table 83. GlaxoSmithKline Recent Developments
Table 84. Southwest Oncology Group Company Details
Table 85. Southwest Oncology Group Business Overview
Table 86. Southwest Oncology Group Biliary Tumor Product
Table 87. Southwest Oncology Group Revenue in Biliary Tumor Business (2019-2024) & (US$ Million)
Table 88. Southwest Oncology Group Recent Developments
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biliary Tumor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Biliary Tumor Market Share by Type: 2023 VS 2030
Figure 3. Mecine Features
Figure 4. Surgery Features
Figure 5. Other Features
Figure 6. Global Biliary Tumor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Biliary Tumor Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Other Case Studies
Figure 11. Biliary Tumor Report Years Considered
Figure 12. Global Biliary Tumor Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Biliary Tumor Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Biliary Tumor Market Share by Region: 2023 VS 2030
Figure 15. Global Biliary Tumor Market Share by Players in 2023
Figure 16. Global Top Biliary Tumor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biliary Tumor as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Biliary Tumor Revenue in 2023
Figure 18. North America Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Biliary Tumor Market Share by Type (2019-2030)
Figure 20. North America Biliary Tumor Market Share by Application (2019-2030)
Figure 21. North America Biliary Tumor Market Share by Country (2019-2030)
Figure 22. United States Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Biliary Tumor Market Size YoY (2019-2030) & (US$ Million)
Figure 25. Europe Biliary Tumor Market Share by Type (2019-2030)
Figure 26. Europe Biliary Tumor Market Share by Application (2019-2030)
Figure 27. Europe Biliary Tumor Market Share by Country (2019-2030)
Figure 28. Germany Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. China Biliary Tumor Market Size YoY (2019-2030) & (US$ Million)
Figure 35. China Biliary Tumor Market Share by Type (2019-2030)
Figure 36. China Biliary Tumor Market Share by Application (2019-2030)
Figure 37. Asia Biliary Tumor Market Size YoY (2019-2030) & (US$ Million)
Figure 38. Asia Biliary Tumor Market Share by Type (2019-2030)
Figure 39. Asia Biliary Tumor Market Share by Application (2019-2030)
Figure 40. Asia Biliary Tumor Market Share by Region (2019-2030)
Figure 41. Japan Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. South Korea Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Taiwan Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. India Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Australia Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Biliary Tumor Market Size YoY (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Biliary Tumor Market Share by Type (2019-2030)
Figure 49. Middle East, Africa, and Latin America Biliary Tumor Market Share by Application (2019-2030)
Figure 50. Middle East, Africa, and Latin America Biliary Tumor Market Share by Country (2019-2030)
Figure 51. Brazil Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Mexico Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Turkey Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Israel Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. GCC Countries Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. NuCana Revenue Growth Rate in Biliary Tumor Business (2019-2024)
Figure 58. NeoGenomics Revenue Growth Rate in Biliary Tumor Business (2019-2024)
Figure 59. Novartis Revenue Growth Rate in Biliary Tumor Business (2019-2024)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Biliary Tumor Business (2019-2024)
Figure 61. Southwest Oncology Group Revenue Growth Rate in Biliary Tumor Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Biliary Tumor Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Mecine
Table 3. Key Players of Surgery
Table 4. Key Players of Other
Table 5. Global Biliary Tumor Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global Biliary Tumor Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Biliary Tumor Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Biliary Tumor Market Share by Region (2019-2024)
Table 9. Global Biliary Tumor Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Biliary Tumor Market Share by Region (2025-2030)
Table 11. Biliary Tumor Market Trends
Table 12. Biliary Tumor Market Drivers
Table 13. Biliary Tumor Market Challenges
Table 14. Biliary Tumor Market Restraints
Table 15. Global Biliary Tumor Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Biliary Tumor Revenue Share by Players (2019-2024)
Table 17. Global Top Biliary Tumor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biliary Tumor as of 2023)
Table 18. Global Biliary Tumor Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by Biliary Tumor Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Biliary Tumor, Headquarters and Area Served
Table 21. Global Key Players of Biliary Tumor, Product and Application
Table 22. Global Key Players of Biliary Tumor, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biliary Tumor Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Biliary Tumor Revenue Market Share by Type (2019-2024)
Table 26. Global Biliary Tumor Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Biliary Tumor Revenue Market Share by Type (2025-2030)
Table 28. Global Biliary Tumor Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Biliary Tumor Revenue Share by Application (2019-2024)
Table 30. Global Biliary Tumor Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Biliary Tumor Revenue Share by Application (2025-2030)
Table 32. North America Biliary Tumor Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America Biliary Tumor Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America Biliary Tumor Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America Biliary Tumor Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America Biliary Tumor Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Biliary Tumor Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Biliary Tumor Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Biliary Tumor Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe Biliary Tumor Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe Biliary Tumor Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe Biliary Tumor Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe Biliary Tumor Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe Biliary Tumor Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe Biliary Tumor Market Size by Country (2025-2030) & (US$ Million)
Table 46. China Biliary Tumor Market Size by Type (2019-2024) & (US$ Million)
Table 47. China Biliary Tumor Market Size by Type (2025-2030) & (US$ Million)
Table 48. China Biliary Tumor Market Size by Application (2019-2024) & (US$ Million)
Table 49. China Biliary Tumor Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia Biliary Tumor Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia Biliary Tumor Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia Biliary Tumor Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia Biliary Tumor Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Biliary Tumor Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia Biliary Tumor Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia Biliary Tumor Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Biliary Tumor Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Biliary Tumor Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Biliary Tumor Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Biliary Tumor Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Biliary Tumor Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America Biliary Tumor Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Biliary Tumor Market Size by Country (2025-2030) & (US$ Million)
Table 64. NuCana Company Details
Table 65. NuCana Business Overview
Table 66. NuCana Biliary Tumor Product
Table 67. NuCana Revenue in Biliary Tumor Business (2019-2024) & (US$ Million)
Table 68. NuCana Recent Developments
Table 69. NeoGenomics Company Details
Table 70. NeoGenomics Business Overview
Table 71. NeoGenomics Biliary Tumor Product
Table 72. NeoGenomics Revenue in Biliary Tumor Business (2019-2024) & (US$ Million)
Table 73. NeoGenomics Recent Developments
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Biliary Tumor Product
Table 77. Novartis Revenue in Biliary Tumor Business (2019-2024) & (US$ Million)
Table 78. Novartis Recent Developments
Table 79. GlaxoSmithKline Company Details
Table 80. GlaxoSmithKline Business Overview
Table 81. GlaxoSmithKline Biliary Tumor Product
Table 82. GlaxoSmithKline Revenue in Biliary Tumor Business (2019-2024) & (US$ Million)
Table 83. GlaxoSmithKline Recent Developments
Table 84. Southwest Oncology Group Company Details
Table 85. Southwest Oncology Group Business Overview
Table 86. Southwest Oncology Group Biliary Tumor Product
Table 87. Southwest Oncology Group Revenue in Biliary Tumor Business (2019-2024) & (US$ Million)
Table 88. Southwest Oncology Group Recent Developments
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biliary Tumor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Biliary Tumor Market Share by Type: 2023 VS 2030
Figure 3. Mecine Features
Figure 4. Surgery Features
Figure 5. Other Features
Figure 6. Global Biliary Tumor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Biliary Tumor Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Other Case Studies
Figure 11. Biliary Tumor Report Years Considered
Figure 12. Global Biliary Tumor Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Biliary Tumor Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Biliary Tumor Market Share by Region: 2023 VS 2030
Figure 15. Global Biliary Tumor Market Share by Players in 2023
Figure 16. Global Top Biliary Tumor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biliary Tumor as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Biliary Tumor Revenue in 2023
Figure 18. North America Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Biliary Tumor Market Share by Type (2019-2030)
Figure 20. North America Biliary Tumor Market Share by Application (2019-2030)
Figure 21. North America Biliary Tumor Market Share by Country (2019-2030)
Figure 22. United States Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Biliary Tumor Market Size YoY (2019-2030) & (US$ Million)
Figure 25. Europe Biliary Tumor Market Share by Type (2019-2030)
Figure 26. Europe Biliary Tumor Market Share by Application (2019-2030)
Figure 27. Europe Biliary Tumor Market Share by Country (2019-2030)
Figure 28. Germany Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. China Biliary Tumor Market Size YoY (2019-2030) & (US$ Million)
Figure 35. China Biliary Tumor Market Share by Type (2019-2030)
Figure 36. China Biliary Tumor Market Share by Application (2019-2030)
Figure 37. Asia Biliary Tumor Market Size YoY (2019-2030) & (US$ Million)
Figure 38. Asia Biliary Tumor Market Share by Type (2019-2030)
Figure 39. Asia Biliary Tumor Market Share by Application (2019-2030)
Figure 40. Asia Biliary Tumor Market Share by Region (2019-2030)
Figure 41. Japan Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. South Korea Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Taiwan Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. India Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Australia Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Biliary Tumor Market Size YoY (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Biliary Tumor Market Share by Type (2019-2030)
Figure 49. Middle East, Africa, and Latin America Biliary Tumor Market Share by Application (2019-2030)
Figure 50. Middle East, Africa, and Latin America Biliary Tumor Market Share by Country (2019-2030)
Figure 51. Brazil Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Mexico Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Turkey Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Israel Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. GCC Countries Biliary Tumor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. NuCana Revenue Growth Rate in Biliary Tumor Business (2019-2024)
Figure 58. NeoGenomics Revenue Growth Rate in Biliary Tumor Business (2019-2024)
Figure 59. Novartis Revenue Growth Rate in Biliary Tumor Business (2019-2024)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Biliary Tumor Business (2019-2024)
Figure 61. Southwest Oncology Group Revenue Growth Rate in Biliary Tumor Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Circuit Simulator Market Research Report 2025
Mar 11, 25
Global Schematic Editor Market Research Report 2025
Mar 11, 25
Global Milk Green Tea Market Research Report 2025
Mar 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232